Sign-up for Galena Biopharma to Present GALE-401 (Anagrelide Controlled Release) Phase 1 Clinical Trial Data at the 56th American Society of Hematology (ASH) Annual Meeting & Exposition investment picks
By Sven Grundberg
STOCKHOLM--Swedish telecommunications operator TeliaSonera AB (TLSN.SK) is facing hurdles completing the acquisition of Tele2 AB's (TEL2-B.SK) Norwegian telecom operations, as Norway's competition authority has raised objections to the deal.
Molina Healthcare, Inc. (NYSE:MOH) announced that, effective today, its
wholly owned subsidiary Molina Healthcare of Florida, Inc. has closed on
its acquisition of certain assets relating to the Florida Medicaid
business of First Coast Advantage, LLC.
Trevena, Inc. (NASDAQ: TRVN), a clinical stage biopharmaceutical company
focused on the discovery and development of G protein coupled receptor
(GPCR) biased ligands, today announced that it intends to offer and sell
$40.0 million of shares of its common stock in an underwritten public
Rexford Industrial Realty, Inc. (the “Company” or “Rexford Industrial”)
(NYSE:REXR), a real estate investment trust focused on owning and
operating industrial properties located in Southern California infill
markets, today announced the acquisition of two industrial properties
containing a combined total of 250,572 rentable square feet, for an
aggregate purchase price of approximately $30.8 million.
At the 2014 MRS Fall Meeting and Exhibit, Bruker (NASDAQ: BRKR) today
announced the release of the UMT
TriboLab™ , the latest generation of the world-leading
Universal Mechanical Tester (UMT) platform.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.